SCHEMBL25329631

SCHEMBL25329631

N#Cc1ccc(N2CCC(c3ccc(OCCN4CCNCC4)cc3)CC2)cc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
AR P10275 8/20 0.43
HRH2 P25021 3/20 0.42
HRH1 P35367 3/20 0.42
HRH3 Q9Y5N1 3/20 0.42
BRD4 O60885 1/20 0.39
KCNH2 Q12809 1/20 0.39
SLC2A1 P11166 1/20 0.39
LTA4H P09960 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30493393 0.87 AR (0.41) ARHRH2HRH1HRH3
SCHEMBL25929504 0.87 AR (0.41) ARHRH2HRH1HRH3
SCHEMBL25934170 0.85 AR (0.47) AR
SCHEMBL25331636 0.85 AR (0.46) AR
SCHEMBL25328831 0.84 AR (0.44) AR
SCHEMBL25329434 0.84 AR (0.42) AR
SCHEMBL30493231 0.84 AR (0.45) ARBRD4KCNH2
SCHEMBL25330053 0.84 AR (0.44) ARHRH2HRH1HRH3
SCHEMBL31131387 0.83 AR (0.42) AR
SCHEMBL25330652 0.83 AR (0.42) AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4466260-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2024-11-27 EP disclosed
WO-2023139199-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2023-07-27 WO disclosed
WO-2023139199-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2023-07-27 WO disclosed